Navigating Melanoma Treatment Challenges: Next-Generation Strategies and Solutions

This book delves into the complexities of melanoma, offering an in-depth examination of the disease alongside the latest advancements in diagnosis and treatment. The initial chapter provides a comprehensive overview of melanoma, covering its fundamentals and introducing the latest technologies shaping the understanding of the disease. The book introduces advanced molecular diagnostics in identifying targetable mutations and tailoring therapies for personalized and effective melanoma treatment. Additionally, it investigates the role of artificial intelligence in melanoma diagnostics and the advancements in imaging technologies for the monitoring and assessment of melanoma. It also reviews novel, innovative immunotherapeutic approaches designed to enhance the body's immune response against melanoma cells. Further, the book delves into the development and application of targeted therapies and nanomedicine in treating melanoma. A dedicated chapter highlights the advantages of a multi-omics approach, integrating genomic, proteomic, and other omics data to achieve a holistic understanding of melanoma. Toward the end, the book examines the potential of combination therapies to improve treatment outcomes in melanoma. The book is a valuable source for cancer researchers, medical oncologists, and clinicians. Key Features Provides a comprehensive overview of melanoma, covering its fundamentals and introducing the latest diagnostics and treatment strategies. Investigates the transformative impact of artificial intelligence in melanoma diagnostics. Focuses on immunotherapeutic advancements against melanoma. Investigates the advancements in targeted therapies and nanomedicine. Explores the synergy of genomics and proteomics in a comprehensive multi-omics approach to melanoma treatment.

About the Author

Zodwa Dlamini is a Professor of Molecular Oncology and the founding Director and the Executive Head of the Pan African Cancer Research Institute (PACRI) in South Africa. She is the Director of South African Medical Research Council (SAMRC) Precision Oncology Research Unit (PORU). She is the DSTI/NRF SARChI Chair in Precision Oncology and Cancer Prevention (POCP). She is a member of the American Association for Cancer Research (AACR) Advisory Group on Sub-Saharan Africa. She is a member of the AACR Pathology Resources in Africa Advisory Group. Professor Dlamini is a member of the African Organisation for Research and Training in Cancer (AORTIC) Research Committee Scientific Advisory Board. She is an elected member of the Academy of Science of South Africa. Professor Dlamini is an overseas Fellow of the Royal Society of Medicine (London) and a member of the New York Academy of Sciences.